Mo-99 production was started recently by Niowave at its Lansing, Michigan facility.
The company is using a superconducting accelerator to manufacture Mo-99 and several other isotopes including iodine-131 (I-131), xenon-133 (Xe-133), and strontium-89 (Sr-89). This approach to the production of Mo-99 rather than relying solely on reactors and highly enriched uranium will help bridge the gaps in Tc-99m supply that occurs within the nuclear medicine imaging community when reactors are down for planned and unplanned maintenance.